ATP2B3 Gene Spinocerebellar Ataxia Type 1 X-linked Genetic Test
Are you concerned about Spinocerebellar Ataxia Type 1? DNA Labs UAE offers the ATP2B3 Gene Spinocerebellar Ataxia Type 1 X-linked Genetic Test to provide you with valuable insights into this genetic disorder.
Test Components and Price
Test Name: ATP2B3 Gene Spinocerebellar Ataxia Type 1 X-linked Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for ATP2B3 Gene Spinocerebellar Ataxia Type 1, X-linked NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with ATP2B3 Gene Spinocerebellar Ataxia Type 1, X-linked
Test Details
The ATP2B3 gene is associated with Spinocerebellar Ataxia Type 1, which is a genetic disorder characterized by progressive degeneration of the cerebellum and other parts of the nervous system. This condition is inherited in an X-linked manner, meaning it primarily affects males.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of Spinocerebellar Ataxia Type 1, an NGS genetic test would involve sequencing the ATP2B3 gene to identify any mutations or variants that may be causing or contributing to the disease.
By analyzing the ATP2B3 gene, NGS genetic testing can help diagnose Spinocerebellar Ataxia Type 1 and provide valuable information for genetic counseling and management of the condition. It can also be used to identify carriers of the gene mutation, which can be important for family planning and reproductive decisions.
It is important to consult with a healthcare professional or a genetic counselor to discuss the appropriateness and availability of NGS genetic testing for Spinocerebellar Ataxia Type 1, as well as the potential implications and limitations of the test results.
Test Name | ATP2B3 Gene Spinocerebellar ataxia type 1 X-linked Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ATP2B3 Gene Spinocerebellar ataxia type 1, X-linked NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP2B3 Gene Spinocerebellar ataxia type 1, X-linked |
Test Details |
The ATP2B3 gene is associated with Spinocerebellar ataxia type 1, which is a genetic disorder characterized by progressive degeneration of the cerebellum and other parts of the nervous system. This condition is inherited in an X-linked manner, meaning it primarily affects males. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of Spinocerebellar ataxia type 1, an NGS genetic test would involve sequencing the ATP2B3 gene to identify any mutations or variants that may be causing or contributing to the disease. By analyzing the ATP2B3 gene, NGS genetic testing can help diagnose Spinocerebellar ataxia type 1 and provide valuable information for genetic counseling and management of the condition. It can also be used to identify carriers of the gene mutation, which can be important for family planning and reproductive decisions. It is important to consult with a healthcare professional or a genetic counselor to discuss the appropriateness and availability of NGS genetic testing for Spinocerebellar ataxia type 1, as well as the potential implications and limitations of the test results. |